Investigating Molecular Reactions to Radiofrequency Microneedling in a 3D Human Skin Model: Insights and Influence of Post-Treatment Care - Scorecard - MDSpire

Investigating Molecular Reactions to Radiofrequency Microneedling in a 3D Human Skin Model: Insights and Influence of Post-Treatment Care

  • By

  • Sebastian Huth

  • Yvonne Marquardt

  • Laura Huth

  • Sina Djahed

  • Jens Malte Baron

  • April 22, 2026

  • 0 min

Share

Clinical Scorecard: Investigating Molecular Reactions to Radiofrequency Microneedling in a 3D Human Skin Model: Insights and Influence of Post-Treatment Care

At a Glance

CategoryDetail
ConditionSkin rejuvenation and related dermatological conditions
Key MechanismsCombines mechanical needle penetration with low-frequency electromagnetic energy to induce neocollagenesis and tissue remodeling while sparing the epidermis.
Target PopulationIndividuals seeking skin rejuvenation, including those with acne scarring, melasma, hair thinning, acne vulgaris, and rosacea.
Care SettingDermatological clinics and aesthetic treatment facilities.

Key Highlights

  • RFMN induces an early pro-inflammatory response with upregulated chemokines and cytokines.
  • Post-treatment with dexpanthenol ointment enhances gene expression related to wound healing.
  • RFMN shows potential for safer skin rejuvenation with reduced downtime.

Guideline-Based Recommendations

Diagnosis

  • Assess skin type and condition prior to RFMN treatment.

Management

  • Utilize RFMN for skin rejuvenation and related dermatological conditions.

Monitoring & Follow-up

  • Observe for signs of inflammation and healing post-treatment.

Risks

  • Potential risks include burns and scarring associated with RFMN devices.

Patient & Prescribing Data

Patients undergoing aesthetic dermatological procedures.

Dexpanthenol-containing ointment may improve healing outcomes and modulate inflammatory responses.

Clinical Best Practices

  • Implement post-treatment care with topical agents to enhance healing.
  • Monitor patients for adverse effects following RFMN.

References

Original Source(s)

Related Content